The estimated valuation of the bleeding control kit market in 2022 was USD 4,265.8 million and is anticipated to reach a valuation of USD 4,365.4 million in 2023.
An increase in the research and development initiatives required in the treatment of various types of blood disorders will also widen the scope for the growth of this market.
According to our researchers, the bleeding control kit market will be anticipated to expand at a CAGR of 2.9% between 2023 and 2033, totaling around USD 5,833.5 million by 2033.
The rising cases of accidents across the globe are set to propel the demand for bleeding control supplies in the upcoming years.
Bleeding control kits are specialized trauma kits that are mainly developed to provide professional responders with the products they require to stop life-threatening bleeding. These can help in controlling excessive bleeding caused by crushing, stabbing, or gunshot wounds.
These are specially designed to stop hemorrhaging and heavy bleeding. These are made to deliver rapid access to life-saving products that can control traumatic hemorrhaging and bleeding.
The rising usage of these kits to rescue workers injured on an assembly line, individuals injured in motorcycle accidents, victims of violent crimes, or hikers injured in remote locations is set to fuel the bleeding control kit market size.
These are expected to be increasingly adopted by municipal buildings, parks, office buildings, and educational institutions to treat victims of active shooter incidents and mass casualty events.
| Attributes | Details |
|---|---|
| Projected Forecast Value (2022) | USD 4,265.8 million |
| Projected Forecast Value (2023) | USD 4,365.4 million |
| Projected Forecast Value (2033) | USD 5,833.5 million |
| Growth rate | 2.9% CAGR |
| Forecast period | 2023 to 2033 |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global bleeding control kit market expanded at a CAGR of 1.9% between 2017 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 2.9% between 2023 and 2033.
Rise in the funding by the federal government hence drives the adoption of bleeding control procedures and their solutions further by influencing the market.
Boost in healthcare expenditure, with the advancements in healthcare infrastructure, and growth in demand for expansion in the care for delivery positively affects the bleeding disorders treatment market.
Increasing Number of Awareness Programs by Government Bodies
The increasing number of awareness programs by government bodies to make people understand the significance of bleeding control kits after an accident occurs is likely to drive the market.
The easy availability of such kits like first aid kits, and emergency kits in supermarkets and local medical stores is another factor that is expected to augur well for the market.
The rising cases of injuries resulting from trauma which may often lead to partial paralysis are anticipated to compel healthcare professionals to deliver quick treatment to patients. This is one of the major factors that is set to boost the sales of bleeding control kits in the near future.
Lack of Skilled Healthcare Professionals
The inability of bleeding control kits to treat abrasions, frostbite, and burns may hinder their demand in specific areas. The lack of skilled healthcare professionals, especially in emerging economies is another vital factor that may hinder the growth in this market.
In addition to that, the expensive nature of state-of-the-art bleeding control procedures can decline their sales in these countries.
| Region/Country | The United States |
|---|---|
| Key Growth Factors |
|
| Key Statistic | Captured a market share of 23.2% in 2022. |
| Region/Country | North America |
|---|---|
| Key Growth Factors | Favorable reimbursement policies and government support in terms of funding positively affect the regional market. |
| Key Statistic | Estimated to record a value share of 27.8% in 2022. |
| Region/Country | China |
|---|---|
| Key Growth Factors |
|
| Key Statistic | Anticipated to develop a 4.5% CAGR from 2023 to 2033. |
| Region/Country | India |
|---|---|
| Key Growth Factors |
|
| Key Statistic | Forecasted to record at 5.2% CAGR from 2023 to 2033. |
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
| Category | Product |
|---|---|
| Sub Category | Tourniquet |
| Key Growth Factors |
|
| Key Statistics | Attained a market share of 37.8% in 2022. |
| Category | End-user |
|---|---|
| Sub Category | Hospitals |
| Key Growth Factors |
|
| Key Statistics | Captured a market share of 27.3%% in 2022. |
Some of the leading companies operating in the global bleeding control supplies market include VBM Medizintechnik, TyTek Medical, Stryker, Hammarplast Medical, Tactical Medical Solutions, Friedrich Bosch Medizintechnik, North American Rescue, Rudolf Riester, Zimmer Biomet, Cardinal Health, Delfi Medical, and Ulrich Medical among others.
The majority of the leading players are focusing on expanding their geographic presence by developing new manufacturing facilities, especially in the untapped regions. Meanwhile, a few other companies are aiming to launch novel products and engage in collaborations with local firms to gain a competitive edge in this market.
Some of the new developments are-
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 2.9% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2017 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, End User, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East and Africa |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Rest of Latin America, Germany, The United Kingdom, France, Spain, Italy, Rest of Western Europe, Poland, Russia, Czech Republic, Romania, Rest of Eastern Europe, India, Bangladesh, Australia, New Zealand, Rest of South Asia and the Pacific, China, Japan, South Korea, GCC countries, South Africa, Israel, Rest of the Middle East and Africa |
| Key Companies Profiled | VBM Medizintechnik; TyTek Medical; Stryker; Hammarplast Medical; Tactical Medical Solutions; Friedrich Bosch Medizintechnik; North American Rescue; Rudolf Riester; Zimmer Biomet; Cardinal Health |
The market in 2023 is valued at USD 4,365.4 million.
The market rose at a 1.9% CAGR from 2017 to 2022.
Until 2033, the market will experience a 2.9% CAGR.
The market shall reach USD 5,833.5 million in 2033.
The market in 2022 was valued at USD 4,265.8 million.
| Market Value (2022) | USD 4.1 Billion |
|---|---|
| Market Value (2032) | USD 7.6 Billion |
| Market CAGR (2022 to 2032) | 3% |
Explore Medical Supplies Insights
View Reports
Bleeding Control Kit Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
